Hochschulschrift
Therapeutic strategies of liver cirrhosis with portal hypertension
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
31 cm
- Umfang
-
103 S.
- Sprache
-
Englisch
- Anmerkungen
-
graph. Darst
Enth. 2 Sonderabdr. aus: Laboratory Investigation 2012 und: Journal of Hepatology 2012
Leipzig, Univ., Diss., 2013
- Klassifikation
-
Medizin, Gesundheit
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Cyclic GMP in liver cirrhosis - role in pathophysiology of portal hypertension and therapeutic implications
Colonic mucosal changes in Egyptian patients with liver cirrhosis and portal hypertension
Advances and challenges in cirrhosis and portal hypertension
Portal hypertension in cirrhosis : Pathophysiological mechanisms and therapy
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study
Transient portal vein thrombosis in liver cirrhosis
Liver cirrhosis
Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension
Emerging Therapeutic Targets for Portal Hypertension
AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model
Hepatic Histoplasmosis Masquerading as Cirrhosis and Portal Hypertension: A Case Report
Cyclic GMP in liver cirrhosis - role in pathophysiology of portal hypertension and therapeutic implications
Colonic mucosal changes in Egyptian patients with liver cirrhosis and portal hypertension
Advances and challenges in cirrhosis and portal hypertension
Portal hypertension in cirrhosis : Pathophysiological mechanisms and therapy
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study
Transient portal vein thrombosis in liver cirrhosis
Liver cirrhosis
Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension
Emerging Therapeutic Targets for Portal Hypertension
AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model
Hepatic Histoplasmosis Masquerading as Cirrhosis and Portal Hypertension: A Case Report
Cyclic GMP in liver cirrhosis - role in pathophysiology of portal hypertension and therapeutic implications
Colonic mucosal changes in Egyptian patients with liver cirrhosis and portal hypertension
Advances and challenges in cirrhosis and portal hypertension
Portal hypertension in cirrhosis : Pathophysiological mechanisms and therapy
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study
Transient portal vein thrombosis in liver cirrhosis
Liver cirrhosis
Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension
Emerging Therapeutic Targets for Portal Hypertension
AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model